News
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Eli Lilly and Company (NYSE:LLY) is among the 12 Best Ethical Companies to Invest in 2025. Eli Lilly and Company (NYSE:LLY) ...
These healthcare leaders still could perform well in the long run. Novo Nordisk has been facing several challenges that ...
For RFK Jr. and his antivax supporters and associates, aluminum adjuvants in some required children’s vaccines appear to be ...
Explore more
This article delves into the approved weight loss drugs in India, their costs, and the growing market for such medications.
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
During the hearing, an official from Novo Nordisk will be questioned about the pricing they charge for Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results